Stay Informed on Corporate Sustainability
Explore industry news, insights, and updates from the Pharma Industry Awards.
Sort by 
AstraZeneca reverses UK investment pause with £300m commitment across two sites
British pharmaceutical giant AstraZeneca has reversed its investment pause to commit £300 million across its Cambridge and Macclesfield sites in the UK, unfreezing a paused £200 million Cambridge expansion and committing £100 million to a Macclesfield laboratory.
Dr. Falk Pharma and Renexxion report positive Phase 2b results for naronapride in gastroparesis
German pharmaceutical company Dr. Falk Pharma and Irish clinical-stage biopharmaceutical firm Renexxion have announced positive Phase 2b trial results for naronapride in adults with gastroparesis, meeting the primary endpoint across two dose groups.
AstraZeneca opens new API manufacturing facility in Dublin with advanced automation and AI
AstraZeneca has officially opened a new active pharmaceutical ingredient manufacturing facility in Dublin, integrating advanced automation, artificial intelligence, and innovative technologies to support its global oncology portfolio and broader medicines pipeline.
Winners announced at the 2026 Women in Pharma Awards
The 2026 Women in Pharma Awards gala took place on 29 April at the Crowne Plaza Hotel, Santry, honouring outstanding women across Ireland's pharma and life sciences sector. Emma Kilgallon of West Pharmaceutical Services received the Overall Leader Award as the evening's top honour, with winners named across more than fifteen categories.
PCI Pharma Services commits over $1 billion to expand sterile fill-finish and drug-device capabilities
US-based global CDMO PCI Pharma Services has announced a series of major infrastructure investments exceeding $1 billion across its US and European operations, substantially expanding its sterile fill-finish and drug-device combination delivery capabilities.
Aptus Pharma doubles revenue and expands portfolio to 250 formulations in growth push
India-based BSE SME-listed Aptus Pharma Limited has doubled its revenue and expanded its product portfolio to over 250 formulations, as the pharmaceutical company accelerates multi-vertical expansion toward pan-India presence by 2030.
Helus Pharma adds Dr. Robert Langer and Dr. Stephen Brannan to Scientific Advisory Board
Clinical-stage pharmaceutical company Helus Pharma has appointed renowned biotechnology pioneer Dr. Robert Langer and CNS drug development expert Dr. Stephen Brannan to its Scientific Advisory Board to advance its mental health pipeline.
Amneal Pharmaceuticals enters US commercial market with first inhalation products from Tipperary
Tipperary-based Amneal Pharmaceuticals has launched its first two metered-dose inhalation products on the US commercial market, marking a significant milestone for the Cashel facility and the wider Tipperary regional economy.
Helus Pharma partners with TARA Mind to support veteran recruitment for HLP003 trial
Helus Pharma has partnered with TARA Mind and Veterans Exploring Treatment Solutions to support veteran recruitment for the clinical-stage pharmaceutical company’s Phase 3 PARADIGM HLP003 programme for major depressive disorder.
Record Exports, Record Ambition: How GLP-1 Medicines Reshaped Ireland’s Pharmaceutical Landscape
Ireland’s pharmaceutical exports hit a record €139 billion in 2025, driven by surging GLP-1 medicine component production. The Goodbody Economic Report for IPHA sets an agenda for sustaining Ireland’s position as the EU’s second-largest pharmaceutical exporter.
Discover What's Happening
Explore our newsletters
Join our Newsletter to receive the latest industry trends, expert tips, and exclusive insights delivered straight to your inbox!
.png)
